611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Women's Health
Basic InformationLatest News
Mom's Weight-Loss Surgery Lowers Many Pregnancy Complications, Raises OthersPregnant Women Need to Take Care in Sweltering Summer HeatAre Antibiotics Really the Answer for UTIs in Women?Stronger Hearts, Better Outcomes in Pregnancy: StudyCould Menopausal Hormone Therapy Reduce Women's Odds for Dementia?Screening Often Misses Endometrial Cancer in Black WomenAHA News: Pregnant Mom's Diet May Influence Baby's Cardiovascular HealthPandemic Delays in Screening Mean More Breast Cancer Deaths Ahead: StudyUrinary Incontinence Can Affect a Woman's Mental HealthCOVID Vaccine Doesn't Infiltrate Breast MilkGap in Breast Cancer Survival for Black, White Patients Shrinks, But Not by EnoughCost a Barrier to Cervical Cancer Screening for Many U.S. WomenAlcohol Still a Threat in Too Many American Pregnancies: StudyWomen's Cancer Screenings Plummeted During PandemicPandemic Day Care Closures Forced 600,000 U.S. Working Moms to Leave JobsNo Sign Prior COVID Infection Affects a Woman's Fertility: StudyFertility Drugs Won't Raise Breast Cancer RiskMigraines Tied to Higher Odds for Complications in PregnancyWomen, Take These Key Steps to Good Urological HealthAre Women Absorbing Toxins From Their Makeup?Race Doesn't Affect Risk for Genes That Raise Breast Cancer RiskHealthy Levels of Vitamin D May Boost Breast Cancer OutcomesHeavy Drinking Could Lower a Woman's Odds of ConceptionAHA News: Asian and Pacific Islander Women May Be at Greatest Risk for Preeclampsia ComplicationsFibroid Pain, Bleeding Is Driving Thousands of Women to the ERA Woman's Diet Might Help Her Avoid Breast CancerBreast Cancer's Spread Is More Likely in Black Women, Study FindsDrug Lynparza Could Help Fight Some Early-Stage Breast CancersAHA News: Menopause Before 40 Tied to Higher Stroke RiskHealthy Eating Lowers Pregnancy Complication RiskAortic Tears Are Even More Deadly for Women, Study FindsFDA Warns of Bogus Fertility Claims for Some SupplementsAHA News: Surprisingly Few Women May Have Good Heart Health Before PregnancyOsteoporosis Might Also Raise a Woman's Odds for Hearing LossModerate Use of Hair Relaxers Won't Raise Black Women's Cancer Risk: StudyMammography Rates Plummeted During Pandemic'Yo-Yo' Dieting May Mean Sleepless Nights for WomenGluten Doesn't Trigger 'Brain Fog' for Women Without Celiac Disease: StudyHPV Vaccination Is Lowering U.S. Cervical Cancer RatesSmoggy Air Might Raise Black Women's Odds for FibroidsAHA News: Preterm Deliveries May Pose Long-Term Stroke Risk for MothersWomen Get Help Later Than Men When Heart Attack StrikesLots of Sugary Drinks Doubles Younger Women's Colon Cancer Risk: StudyHeart Risk Factors Show Up Earlier in U.S. Black WomenBetter Access to Birth Control Boosts School Graduation RatesA Vitamin Could Be Key to Women's Pain After Knee ReplacementFreezing Tumors Could Be New Treatment for Low-Risk Breast CancersGiving Birth During the Pandemic? Facts You Need to KnowDo Your Genes Set You Up for Hot Flashes?Common Complication of Pregnancy Tied to Higher Stroke Risk Later
Questions and AnswersLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Wellness and Personal Development
Mental Disorders

An IUD Could Ward Off Endometrial Cancer in Women at Risk

HealthDay News
by By Cara Murez HealthDay Reporter
Updated: Mar 26th 2021

new article illustration

FRIDAY, March 26, 2021 (HealthDay News) -- For some patients who have early endometrial cancer or a precancerous condition, a hysterectomy may not be a good option because of serious health issues or the desire to preserve fertility.

Now, a new Australian study has found that a hormonal IUD might be an effective treatment option for these women.

About 82% of women who had a precancerous condition and used the levonorgestrel IUD -- the same kind a woman might use for birth control -- had a "complete pathological response" (no sign of cancer or precancer in biopsy) after six months, according to the study.

It was less effective in women with cancer -- about 43% responded completely.

"While the chances of a response in endometrial cancer is a lot less, it's still [almost] 50%," said lead investigator Dr. Andreas Obermair, a professor at the University of Queensland Faculty of Medicine in Brisbane.

"Keep in mind these women have basically no treatment choices. They're unsuitable for surgery," he said. "If you would operate on them, they would either run a very high risk of dying as a consequence of this operation or very severe complications from the procedure. Many of these women choose not to have surgery. So, now they have a 50% chance of the cancer completely going away. It's obviously not as high as we want it, but it's 50%."

An example of a woman who may benefit from the IUD used in the study is someone who has severe obesity and may have other serious medical issues such as heart, kidney or lung disease, Obermair said. Another candidate may be young and not want a hysterectomy because she wants to have children.

The study enrolled 165 women between December 2012 and October 2019, with 154 completing the six-month follow-up. They were an average age of 53. All participants had obesity, which is a known risk factor for endometrial cancer.

Researchers also considered the responses of 47 women who were treated with the IUD and metformin, a diabetes drug that has potential anti-cancer activity. Another 47 received the IUD and participated in a weight-loss program.

The results after six months ranged from 57% effective for the women who had the IUD and metformin treatment to 67% effective for the women who had the IUD and weight loss.

Complete pathological response at six months doesn't mean the women are cured because the cancer can return, Obermair cautioned.

Endometrial cancer happens when malignant cells form in the endometrium, the lining of the uterus, according to the American Cancer Society. Symptoms can include vaginal bleeding and pain.

It is the most common gynecologic cancer. About 60,000 cases will be diagnosed this year in the United States, according to the cancer society.

Not all women are poor candidates for surgery. The standard care for endometrial cancer is a total hysterectomy, which includes removing the uterus, cervix, fallopian tubes and ovaries.

"I'm not suggesting that the standard treatment of endometrial cancer should shift from surgery to hormone IUD," Obermair said. "I'm only suggesting that a subgroup of women, those may be about 10, 20% of women who are very poor surgical candidates, they should be offered an alternative."

Dr. Konstantin Zakashansky, director of the division of minimally invasive gynecologic surgery for the Mount Sinai Health System in New York City, called the response rates for precancer patients "very good and encouraging," but expressed concern about the "much lower response rate than we were anticipating" in the group with cancer.

It will be important to identify why the treatment only worked for 43% of patients with cancer, said Zakashansky, who wasn't involved with the study.

"What about those 60%? How are they different from those 43% who did respond? There may be some underlying molecular explanation for this and that's where we should be looking at," he said.

Zakashansky noted there could be other potential alternative treatment options for this condition.

"There are a lot of interesting new drugs that are coming out, new molecular targets that could potentially be explored," he said. "I think the most important thing is to continue enrolling those patients and to encourage patients getting on clinical trials and investigating those different combinations."

The study was presented at the Society of Gynecologic Oncology's virtual annual meeting, held March 19-25. Findings presented at meetings are considered preliminary until published in a peer-reviewed journal.

"The next step is to identify what factors predict response or non-response," Obermair said. "So, then the next step is to intensify our research efforts to advance this whole field."

More information

The American Cancer Society has more information on treating endometrial cancer.

SOURCES: Andreas Obermair, MD, professor, University of Queensland and director, Queensland Centre for Gynaecological Cancer Research, Brisbane, Australia; Konstantin Zakashansky, MD, director, Division of Minimally Invasive Gynecologic Surgery, Mount Sinai Health System, and associate professor, obstetrics and gynecology, department of obstetrics, gynecology and reproductive science, Icahn School of Medicine at Mount Sinai, New York City; Society of Gynecologic Oncology, virtual annual meeting, March 19-25, 2021